Detalles de la búsqueda
1.
COVID-19 and seizures: Is there a link?
Epilepsia;
61(9): 1840-1853, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32944929
2.
Raloxifene encapsulated spanlastic nanogel for the prevention of bone fracture risk via transdermal administration: Pharmacokinetic and efficacy study in animal model.
Drug Deliv Transl Res;
2023 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37996726
3.
Enhancing Osteoporosis Treatment through Targeted Nanoparticle Delivery of Risedronate: In Vivo Evaluation and Bioavailability Enhancement.
Pharmaceutics;
15(9)2023 Sep 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37765307
4.
Effect of the MAGL/FAAH Dual Inhibitor JZL-195 on Streptozotocin-Induced Alzheimer's Disease-like Sporadic Dementia in Mice with an Emphasis on Aß, HSP-70, Neuroinflammation, and Oxidative Stress.
ACS Chem Neurosci;
13(7): 920-932, 2022 04 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35316021
5.
Octanoic acid a major component of widely consumed medium-chain triglyceride ketogenic diet is detrimental to bone.
Sci Rep;
11(1): 7003, 2021 03 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33772066
6.
Management of COVID-19 in patients with seizures: Mechanisms of action of potential COVID-19 drug treatments and consideration for potential drug-drug interactions with anti-seizure medications.
Epilepsy Res;
174: 106675, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34044300
7.
The role of endocannabinoid pathway in the neuropathology of Alzheimer's disease: Can the inhibitors of MAGL and FAAH prove to be potential therapeutic targets against the cognitive impairment associated with Alzheimer's disease?
Brain Res Bull;
174: 305-322, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34217798
Resultados
1 -
7
de 7
1
Próxima >
>>